Abstract
Leukotrienes are inflammatory mediators that are known as the slow-reacting substance of anaphylaxis produced by a number of cell types, including mast cells, eosinophils, basophils, macrophages, and monocytes. Synthesis of these meditators in the text result from the cleavage of arachidonic acid in cell membranes, and exert their biologic effects by binding and activating specific adaptors. This occurs in a serious of events that lead to contraction of the human airway smooth muscle, chemotaxis, and increased vascular permeability. These effects have lead to their important role in the diseases of asthma, allergic rhinitis, and possible paranasal sinusitis with the formation of nasal polyps. Since these agents lead to the production of symptoms in patients who are asthmatic, the use of leukotriene enzyme inhibitors, particularly montelukast, zafirlukasts seem appropriate.
References
Dec 20, 1990·The New England Journal of Medicine·H R Knapp
May 1, 1991·The American Review of Respiratory Disease·R M NaclerioA G Togias
Mar 1, 1990·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·B K FlowersR M Naclerio
Dec 1, 1990·Archives of Otolaryngology--head & Neck Surgery·B K FlowersR M Naclerio
Apr 1, 1988·The American Review of Respiratory Disease·N R FerreriH L Spiegelberg
Feb 1, 1987·The Laryngoscope·T T JungR Stewart
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·A L DonnellyT B Casale
Dec 1, 1994·The Journal of Allergy and Clinical Immunology·A R FischerJ M Drazen
Nov 1, 1995·American Journal of Otolaryngology·I KlapanV Miljenko
Jan 1, 1996·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·R A Nathan
Feb 1, 1997·Chest·P M O'Byrne
Feb 1, 1997·Chest·N C BarnesT Miyamoto
Oct 6, 1997·Annals of Internal Medicine·P M O'ByrneJ M Drazen
Feb 7, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S PintoR Abbate
Apr 4, 1998·Current Opinion in Pulmonary Medicine·R A Tan
Apr 29, 1998·JAMA : the Journal of the American Medical Association·B KnorrA Becker
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·B DahlénS E Dahlén
Jul 1, 1998·American Journal of Respiratory and Critical Care Medicine·J Drazen
Nov 24, 1998·The Netherlands Journal of Medicine·Z DiamantP N Dekhuijzen
Jan 23, 1999·The New England Journal of Medicine·J M DrazenP M O'Byrne
Mar 13, 1999·Annals of Internal Medicine·K MalmstromT F Reiss
May 13, 1999·Journal of Clinical Pharmacy and Therapeutics·J MissonM J Kendall
May 13, 1999·Acta Oto-laryngologica·M SchmidM E Wigand
May 15, 1999·ORL; Journal for Oto-rhino-laryngology and Its Related Specialties·J GosepathW J Mann
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·C PicadoJ Mullol
Jul 28, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·W W BusseR J Horwitz
Citations
Sep 30, 2003·Current Opinion in Otolaryngology & Head and Neck Surgery·James N Palmer, David W Kennedy
May 8, 2007·Prostaglandins & Other Lipid Mediators·Paul Rubin, Karl W Mollison
Jan 19, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R J SalibP H Howarth
May 6, 2004·Current Opinion in Allergy and Clinical Immunology·De-Yun WangBruce R Gordon
Apr 26, 2013·Journal of Pharmacological Sciences·Wakana KurodaNoriaki Takeda
May 22, 2019·The Journal of Antibiotics·Ken-Ichi Kimura
Mar 9, 2018·Fitoterapia·Miku MaruyamaKen-Ichi Kimura
Jun 21, 2021·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Jing ZhouYunhai Feng